Loading...
EssilorLuxottica SA
EL.PA•EURONEXT
HealthcareMedical - Instruments & Supplies
€248.30
€2.80(1.14%)
EssilorLuxottica SA (EL.PA) Financial Performance & Statements
Review EssilorLuxottica SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
4.38%
↑ 4.38%
Operating Income Growth
8.56%
↑ 8.56%
Net Income Growth
3.06%
↑ 3.06%
Operating Cash Flow Growth
0.27%
↑ 0.27%
Operating Margin
13.007%
↑ 13.007%
Gross Margin
62.52%
↑ 62.52%
Net Profit Margin
8.90%
↑ 8.90%
ROE
5.94%
↑ 5.94%
ROIC
6.42%
↑ 6.42%
EssilorLuxottica SA (EL.PA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for EssilorLuxottica SA stock.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $13.22B | $13.29B | $12.54B | $12.85B |
| Cost of Revenue | $5.05B | $4.88B | $4.70B | $4.62B |
| Gross Profit | $8.17B | $8.41B | $7.85B | $8.23B |
| Gross Profit Ratio | $0.62 | $0.63 | $0.63 | $0.64 |
| R&D Expenses | $184.00M | $446.00M | $293.00M | $300.00M |
| SG&A Expenses | $6.34B | $6.13B | $6.15B | $6.04B |
| Operating Expenses | $6.66B | $6.46B | $6.44B | $6.34B |
| Total Costs & Expenses | $11.71B | $11.35B | $11.14B | $10.96B |
| Interest Income | $0.00 | $0.00 | $55.00M | $30.00M |
| Interest Expense | $0.00 | $79.00M | $108.00M | $90.00M |
| Depreciation & Amortization | $2.07B | $1.03B | $1.49B | $1.46B |
| EBITDA | $3.63B | $3.00B | $2.88B | $3.31B |
| EBITDA Ratio | $0.27 | $0.23 | $0.23 | $0.26 |
| Operating Income | $1.50B | $1.94B | $1.41B | $1.89B |
| Operating Income Ratio | $0.11 | $0.15 | $0.11 | $0.15 |
| Other Income/Expenses (Net) | -$74.00M | -$83.00M | -$130.00M | -$130.00M |
| Income Before Tax | $1.43B | $1.86B | $1.28B | $1.76B |
| Income Before Tax Ratio | $0.11 | $0.14 | $0.10 | $0.14 |
| Income Tax Expense | $372.00M | $428.00M | $287.00M | $322.00M |
| Net Income | $994.00M | $1.36B | $928.00M | $1.36B |
| Net Income Ratio | $0.08 | $0.10 | $0.07 | $0.11 |
| EPS | $2.15 | $3.02 | $2.05 | $3.06 |
| Diluted EPS | $2.15 | $2.98 | $2.05 | $3.03 |
| Weighted Avg Shares Outstanding | $461.78M | $452.08M | $452.03M | $445.29M |
| Weighted Avg Shares Outstanding (Diluted) | $461.42M | $458.60M | $453.13M | $449.17M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan